Patients with relapsing-remitting multiple sclerosis show accelerated whole brain volume and thalamic volume loss early in disease

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Roland Opfer - , jung diagnostics GmbH (Author)
  • Matthias Schwab - , Jena University Hospital (Author)
  • Sabine Bangoura - , Bristol-Myers Squibb (Author)
  • Mousumi Biswas - , Bristol-Myers Squibb (Author)
  • Julia Krüger - , jung diagnostics GmbH (Author)
  • Lothar Spies - , jung diagnostics GmbH (Author)
  • Carola Gocke - , Conradia Medical Prevention Hamburg (Author)
  • Christian Gaser - , Jena University Hospital (Author)
  • Sven Schippling - , University Hospital Zurich, University of Zurich (Author)
  • Hagen H Kitzler - , Institute and Polyclinic of Diagnostic and Interventional Neuroradiology, Institute and Polyclinic of Diagnostic and Interventional Neuroradiology (Author)
  • Tjalf Ziemssen - , Department of Neurology, University Hospital Carl Gustav Carus Dresden (Author)

Abstract

BACKGROUND: The aim of this study was to investigate the dynamics of annual whole brain volume loss (BVL/year) and annual thalamic volume loss (ThalaVL/year) in patients with relapsing-remitting multiple sclerosis (PwRRMS) during the course of the disease.

METHODS: A longitudinal database of magnetic resonance imaging (MRI) scans of 195 healthy individuals (age range, 22.8-63.7 years) and longitudinal MRI data of 256 PwRRMS (age range, 20.1-60.8 years) were analyzed and compared. BVL/year and ThalaVL/year were computed for healthy individuals as well as for all patients with MS using a Jacobian integration approach. A linear regression was used to compute the relationship between age and BVL/year and ThalaVL/year for healthy individuals. The linear regression was then used to decompose the BVL/year and ThalaVL/year into a multiple sclerosis (MS)-related and an age-related component for each PwRRMS. PwRRMS were dichotomized into early-phase RRMS (disease duration ≤ 6 years) and later-phase RRMS (disease duration > 6 years), and a t-test was performed to test for differences between these groups.

RESULTS: The 135 early-phase patients (disease duration, ≤ 6 years) had statistically significantly higher MS-related BVL/year than the later-phase patients (n = 121) (- 0.21% vs. - 0.06%, p = 0.007). For MS-related ThalaVL/year, the difference between the groups was even more pronounced (- 0.39% vs. - 0.00%, p < 0.0001).

CONCLUSIONS: Our results indicate that in PwRRMS, the MS-related components of BVL/year and ThalaVL/year are accelerated in early phases and slowdown in later phases of the disease. This might explain why early intervention often leads to improved outcomes in patients with MS.

Details

Original languageEnglish
JournalNeuroradiology
Publication statusE-pub ahead of print - 28 Nov 2024
Peer-reviewedYes

External IDs

ORCID /0000-0001-8799-8202/work/173055420

Keywords